Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Blueprint Genetics | RCV001074684 | SCV001240277 | likely pathogenic | Retinal dystrophy | 2019-03-22 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000085373 | SCV001247766 | pathogenic | not provided | 2023-04-01 | criteria provided, single submitter | clinical testing | ABCA4: PVS1, PM3:Strong, PM2 |
Labcorp Genetics |
RCV000085373 | SCV004293334 | pathogenic | not provided | 2024-01-11 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu37Trpfs*3) in the ABCA4 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ABCA4 are known to be pathogenic (PMID: 10958761, 24938718, 25312043, 26780318). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Stargardt disease (PMID: 10090887, 32531858). ClinVar contains an entry for this variant (Variation ID: 99030). For these reasons, this variant has been classified as Pathogenic. |
Institute of Human Genetics, |
RCV001074684 | SCV005072626 | pathogenic | Retinal dystrophy | 2020-01-01 | criteria provided, single submitter | clinical testing | |
Retina International | RCV000085373 | SCV000117510 | not provided | not provided | no assertion provided | not provided |